Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plans For Mandatory EU Joint Clinical Assessments Watered Down

Executive Summary

Pharma industry representatives are calling for the proposals on health technology assessment cooperation to include more flexibility on uncertainty in evidence supporting orphans and advanced therapies.

You may also be interested in...



EU Council Agrees Compromise Position On Joint Clinical Assessments

The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.

EU-Wide Joint Clinical Assessments Edge Closer

Legislation that would introduce EU-wide joint clinical assessments has moved a step forward after the European Parliament adopted its version of the proposals.

Industry Welcomes Mandatory EU Joint Clinical Assessments For HTA

Draft proposals to improve EU-wide cooperation on health technology assessments, including mandatory joint clinical assessments, have won support from EFPIA, the European Federation of Pharmaceutical Industries and Associations.

Topics

UsernamePublicRestriction

Register

PS144017

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel